| 标题 |
SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants
|
| 备注 |
无
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Leukemia. 2012 Aug;26(8):1892-5. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)